Indeed, upon LLC1 challenge, mice implanted with ATXN3-null LLC1 cells showed striking tumor rejection compared with those with WT LLC1 cells, with a dramatic reduction in both tumor volumes and weight (Figure 4, A–C). This evidence concerns the gene ATXN3 and neoplasm.